Loading...

KALV KALVISTA PHARMACEUTICALS INC Company Mergers 8-K Filing

KLVS

KLV

KALVISTA PHARMACEUTICALS INC

(KALV)

2026 8-K

Merger Announcement

Financial Results Report

Preliminary Revenue Report

Financial Results

New COO Appointment

Board Appointments

Convertible Notes Offering

Financial Results Revealed

Annual Meeting Update

Financial Statements

New Product Launches

License Agreement

Fiscal Year Change

Financial Results

Management Change

Financial Results

Board Appointment

Revenue Rights Sale

Annual Meeting Results

Management Changes

Financial Results

Lease Agreement

Financial Results

Financial Results

Public Offering

Termination of Sales Agreement

Clinical Data Announcement

Financial Results

Amendment to Certificate of...

Financial Results

Amended Employment Agreement

Financial Results

Appointment of President

External Links:

On April 29, 2026, KalVista Pharmaceuticals, Inc. announced a merger agreement with Chiesi Farmaceutici S.p.A. to offer $27.00 for each of its outstanding shares, pending various conditions. This transaction will result in KalVista becoming a wholly owned subsidiary of Chiesi.

AI Assistant

KALVISTA PHARMACEUTICALS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.